SCHEMBL2486256

SCHEMBL2486256

O=CCc1ccsc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4763072 0.76 SLC6A4 (0.37)
SCHEMBL31467964 0.76
Formic Acid SCHEMBL29148169 0.75 SLC6A4 (0.39)
SCHEMBL8508207 0.75 SLC6A4 (0.36)
SCHEMBL1548500 0.75
SCHEMBL25371975 0.74
SCHEMBL15706625 0.74 SLC6A4 (0.43)
SCHEMBL12917335 0.74 SLC6A4 (0.43)
SCHEMBL27857859 0.74 FFAR4 (0.43)
SCHEMBL725380 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116514622-A Method for simply synthesizing alpha-bromomethyl ketone compound 湖南工学院 2023-08-01 CN disclosed
CN-112898309-A Tricyclic compounds as immunomodulators 正大天晴药业集团股份有限公司 2021-06-04 CN disclosed
CN-108884103-B Tricyclic compounds as immunomodulators 正大天晴药业集团股份有限公司 2021-01-15 CN disclosed
EP-2376489-A1 Alkaloid aminoester derivatives and medicinal composition thereof Chiesi Farmaceutici S.p.A. (IT) 2011-10-19 EP disclosed
WO-2010072338-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITION THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2010-07-01 WO disclosed
EP-1658285-A1 COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON LIKE PEPTIDE (GLP)-1 COMPOUND OR AN MELANOCORTIN 4 RECEPTOR (MC4) AGONIST PEPTIDE ELI LILLY AND COMPANY (US) 2006-05-24 EP disclosed
WO-2005019212-A1 COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON LIKE PEPTIDE (GLP)-1 COMPOUND OR AN MELANOCORTIN 4 RECEPTOR (MC4) AGONIST PEPTIDE ELI LILLY AND COMPANY (US) 2005-03-03 WO disclosed